(Total Views: 597)
Posted On: 04/23/2021 12:16:23 AM
Post# of 157302
“HIV, COVID and Oncology”
Serious indications. This is still such an undervalued stock IMO. I’m buying note this week at this point. I’m addicted to buying shares.
My questions is when is CD16 and CD17 going to get the show on the road!? Second wave or the real second wave sounds like it’s coming. It would be nice to get Leronlimab available......
Serious indications. This is still such an undervalued stock IMO. I’m buying note this week at this point. I’m addicted to buying shares.
My questions is when is CD16 and CD17 going to get the show on the road!? Second wave or the real second wave sounds like it’s coming. It would be nice to get Leronlimab available......
(2)
(0)
Daniel Rizzo
Federal Whistleblower
Case References
• HHS & SEC Whistleblower: HL-1412396
• DOJ Investigation Report / Whistleblower ID: 20250705-0001
• NIH Case Reference: CS1137565
• DoD Case: 16282
• IC IG / 50 U.S.C. §3033 / ARPA-H (Advanced Research Projects Agency for Health)
Founder & CEO
FireGate BioTech | AI Lux Veritas™
Contact FireGate Biotech
Federal Whistleblower
Case References
• HHS & SEC Whistleblower: HL-1412396
• DOJ Investigation Report / Whistleblower ID: 20250705-0001
• NIH Case Reference: CS1137565
• DoD Case: 16282
• IC IG / 50 U.S.C. §3033 / ARPA-H (Advanced Research Projects Agency for Health)
Founder & CEO
FireGate BioTech | AI Lux Veritas™
Contact FireGate Biotech
